Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.

Molecular and Cellular Biology
B C SchaeferS H Speck

Abstract

Epstein-Barr virus (EBV) is capable of adopting three distinct forms of latency: the type III latency program, in which six EBV-encoded nuclear antigens (EBNAs) are expressed, and the type I and type II latency programs, in which only a single viral nuclear protein, EBNA1, is produced. Several groups have reported heavy CpG methylation of the EBV genome in Burkitt's lymphoma cell lines which maintain type I latency, and loss of viral genome methylation in tumor cell lines has been correlated with a switch to type III latency. Here, evidence that the type III latency program must be inactivated by methylation to allow EBV to enter the type I or type II restricted latency program is provided. The data demonstrates that the EBNA1 gene promoter, Qp, active in types I and II latency, is encompassed by a CpG island which is protected from methylation. CpG methylation inactivates the type III latency program and consequently allows the type I or II latency program to operate by alleviating EBNA1-mediated repression of Qp. Methylation of the type III latency EBNA gene promoter, Cp, appears to be essential to prevent type III latency, since EBNA1 is expressed in all latently infected cells and, as shown here, is the only viral antigen r...Continue Reading

References

May 15, 1976·International Journal of Cancer. Journal International Du Cancer·C Sundström, K Nilsson
Feb 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E AltiokI Ernberg
Jan 1, 1992·Analytical Biochemistry·W P Deng, J A Nickoloff
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·H HerbstH Stein
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J SampleE Kieff
Sep 1, 1991·Microbiological Reviews·A Razin, H Cedar
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M WoisetschlaegerS H Speck
May 1, 1987·The Journal of General Virology·A KanamoriK Hirai
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M WoisetschlaegerS H Speck
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·R FåhraeusP Busson
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S H SpeckJ L Strominger
Jul 15, 1972·International Journal of Cancer. Journal International Du Cancer·G KleinB Gothoskar
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·K D LangnerW Doerfler
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·B C SchaeferS H Speck
Feb 24, 1995·Cell·E M MiyashitaD A Thorley-Lawson
Nov 1, 1995·The Journal of Experimental Medicine·K JonesG Tosato
Mar 20, 1995·Analytical Biochemistry·A M RaizisJ P Jost
Jan 1, 1994·Human Molecular Genetics·P W Laird, R Jaenisch

❮ Previous
Next ❯

Citations

Apr 23, 2013·Current Opinion in Virology·Horng-Shen ChenPaul M Lieberman
Apr 1, 2011·European Journal of Cell Biology·Markus Kalla, Wolfgang Hammerschmidt
Jan 22, 2010·The Journal of General Virology·Neil Blake
Nov 6, 2007·Virology·Leah J Anderson, Richard Longnecker
Nov 5, 1999·Seminars in Cancer Biology·R F AmbinderQ Tao
Sep 13, 2012·PLoS Pathogens·Anne WoellmerWolfgang Hammerschmidt
Oct 5, 2010·PLoS Pathogens·Martin BergbauerWolfgang Hammerschmidt
Aug 11, 2011·PLoS Pathogens·Italo TemperaPaul M Lieberman
Apr 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kuan-Ping YuGeorge Miller
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Markus KallaWolfgang Hammerschmidt
Apr 17, 2018·Cancers·Rob J A VerhoevenHonglin Chen
Mar 29, 2000·Journal of Cellular Physiology·R L Momparler, V Bovenzi
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Katja PokrovskajaLaszlo Szekely
Sep 4, 2007·BMC Systems Biology·Maria WernerErik Aurell
Oct 16, 1999·Science·A P Wolffe, M A Matzke
Oct 28, 2004·Journal of Virology·Charles M Chau, Paul M Lieberman
Sep 30, 2020·Annual Review of Virology·Yonggang PeiErle S Robertson
Sep 19, 2018·Current Opinion in Virology·Thomas C Frost, Benjamin E Gewurz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.